CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase
about
sameAs
Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signalingMIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule networkCD27 and CD40 inhibit p53-independent mitochondrial pathways in apoptosis of B cells induced by B cell receptor ligationTRAF family proteins link PKR with NF-kappa B activationThe atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathwayExpression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cellsMolecular basis for CD40 signaling mediated by TRAF3Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsThe role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosisActivation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motifTumor necrosis factor receptor-associated factors (TRAFs)Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activationStimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer.Identification of Nd1, a novel murine kelch family protein, involved in stabilization of actin filaments.Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation.Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.Aberrant expression and reverse signalling of CD70 on malignant B cells.The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways.Structural studies of human TRAF2.Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cellsSUMOylation is required for optimal TRAF3 signaling capacityThermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetryAn alternative signal 3: CD8⁺ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling.Identification of functionally distinct TRAF proinflammatory and phosphatidylinositol 3-kinase/mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (PI3K/MEK) transforming activities emanating from RET/PTC fusion oncoproteinStabilization of RNT-1 protein, runt-related transcription factor (RUNX) protein homolog of Caenorhabditis elegans, by oxidative stress through mitogen-activated protein kinase pathwayElimination of chronic viral infection by blocking CD27 signaling.Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activationc-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity.The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymusTranslating insights from persistent LCMV infection into anti-HIV immunity.CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients.Disruption of Tumor Necrosis Factor Receptor-Associated Factor 5 Exacerbates Murine Experimental Colitis via Regulating T Helper Cell-Mediated InflammationRoles of TRAF molecules in B lymphocyte functionTransition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapyTRAF molecules in cell signaling and in human diseasesEndotoxin-Induced IL-6 Promoter Activation in Skeletal Muscle Requires an NF-κB SiteCD70 as a therapeutic target in human malignancies.TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infectionTNF superfamily: costimulation and clinical applicationsThe role of TNF superfamily members in T-cell function and diseases.
P2860
Q22253441-766E8FE2-2888-4C36-A6D0-67DCA5BD2DB1Q22254016-A0279CC9-D472-4BF0-ADD7-C10718EDA2D6Q24307766-496B23C4-D30F-4640-BE85-9214D913636CQ24338458-C5FAC8EB-3B60-470E-84E2-1A3C7AC76D97Q24630760-53EF6E42-265F-4458-A771-0FA585FF4275Q24646465-A7C33BDE-84F9-41BC-B1C3-930CEE869B14Q24656208-169876A7-C0EF-4A6F-9A94-A3693B3A783AQ26853280-A0ABABA4-D425-4797-9407-F673158C530BQ26996707-CAA921A6-277A-4660-970C-4688C80B7004Q28138697-DC3A7212-4BA8-494A-BBB3-4439E93C57A4Q28199382-DD8E9F03-227D-4674-8331-75C3F972D787Q28584897-71B6E62A-9DBD-4D87-8C7D-BC5BD4118EDBQ30252919-E0E12735-76B9-4183-999F-8793F7CCB453Q31108300-CB4CEB9D-0BDA-4228-9C36-144825D6DCB8Q31904245-2A3C1D18-851D-4C96-B34E-B06271F7D4FEQ33815241-DB571A9B-4D1D-4940-BBE0-4274B72368DDQ33872027-7B6C9132-4C0B-4E9A-9F0F-2D9E9238222EQ33953115-AB8CE7ED-5760-41AD-B6D9-3620E9F1F821Q34170952-171F7175-D199-4B18-816A-F19A2DDB16C8Q34582700-897B095E-FB3F-42AF-9503-0D9C8EB7375FQ35049033-2193BD2F-C48A-41A7-82E6-2ADE967B9EE1Q35192167-12480C0F-71CE-4B5C-B4B2-178D783766A2Q35717963-CFFA7D59-7591-4C7A-9C46-CBE9CE2E9BC4Q35763320-84BB4E16-249E-4483-93E6-73C1204F9F34Q35880035-56F499F7-FBDD-4B98-BB5B-78E3A589A1F6Q36228882-95F7C95C-FFAA-49C9-9C72-69958BC39D6EQ36368467-38CC41C9-83B7-4B26-BA5B-340C8BDDEAEAQ36370197-62853763-6F41-4E39-8377-AFE1500086B7Q36370712-DDADFE9F-D376-4C16-B7F1-C076EF7EC12CQ36378994-D5146BF4-5C22-45CC-B33D-D42A48C96D76Q36399628-D59CA610-4D2B-4356-967A-C99619E288B1Q36773555-A1147852-E765-4ED4-ACC1-5C5F312BC84AQ36808885-281E10CC-5D4E-4830-AA7D-C56D6ACEEAB6Q36908563-DFEA3D04-0FFC-4100-AB04-9FD646846026Q36972287-34FE1E7F-B7B4-4907-8373-B413C6E43398Q37019560-806A174B-1A45-436A-B494-8267B62745D8Q37082785-459419D8-3316-4A83-94A0-142EF5956478Q37085756-42854CB5-F717-4CFF-AF9B-6736CDD252A9Q37266849-1ED6A689-0C0F-4735-AC4F-7B14C51B69E7Q37332068-F7EB8D86-D496-4D4C-AA9C-107D2A3086ED
P2860
CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@ast
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@en
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@nl
type
label
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@ast
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@en
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@nl
altLabel
CD27, a Member of the Tumor Ne ...... AF5, and NF- B-inducing Kinase
@ast
CD27, a Member of the Tumor Ne ...... AF5, and NF- B-inducing Kinase
@en
prefLabel
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@ast
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@en
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@nl
P2093
P3181
P356
P1476
CD27, a member of the tumor ne ...... and NF-kappaB-inducing kinase
@en
P2093
C Morimoto
S Nishinaka
P304
13353-13358
P3181
P356
10.1074/JBC.273.21.13353
P407
P577
1998-05-01T00:00:00Z